Skip to content
DraconiticResearch
Search Sources API
197,578 studies31 sourcesUpdated 7 min ago
Peer-reviewedCC BY-NC-NDEJHaem

Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia

  • Angeline Josiah1
  • Ryan Low1
  • Alisha Ganesh1
  • Gretchen Vamvakidis1
  • Adeline Kintono1
  • Ibrahim Tohidi‐Esfahani1
  • Maya Latimer2
  • Judith Trotman1
  1. 1Concord Repatriation General Hospital
  2. 2Australian National University
Read full textPDFCite

Related

  1. FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma
    Rachel Ershler, Xueping Zhou, Keng Hee Peh +12
    Clinical cancer research : an official journal of the American Association for Cancer ResearchPeer-reviewedLicence not statedFull textGeneral medicinePMC
  2. Response to Venetoclax and Azacitidine in Induction-Refractory Adult Acute Myeloid Leukemia with UBTF Tandem Duplication and Associated Aberrant Splicing: A Case Report
    Seigi Oshima, Kazuhisa Chonabayashi, Takashi Sakamoto +11
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  3. Successful Treatment with Rituximab in a Patient with Clinically Suspected Small-vessel Primary Central Nervous System Vasculitis Refractory to Cyclophosphamide Pulse Therapy
    Takuya Okamoto, Kazuki Yokokawa, Bungo Hirose +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  4. Patient-tailored azacitidine, venetoclax and gilteritinib triplet therapy appear to improve tolerability while preserving encouraging clinical outcomes in FLT3-mutated relapsed/refractory AML.
    Matilda Arvidsson Kvissberg, Christer Nilsson, Niklas Landberg +6
    Annals of hematologyPeer-reviewedCC BYFull textGeneral medicineEurope PMCDOAJ
  5. A comparative analysis of semiannual versus annual rituximab maintenance in patients with refractory idiopathic inflammatory myopathies: a retrospective longitudinal real-world study.
    Rodrigo Lorenzetti Serrano, Fernando Henrique Carlos de Souza, Renata Miossi +2
    Revista da Associacao Medica Brasileira (1992)Peer-reviewedCC BYFull textEpidemiology & public healthEurope PMC

Cite

BibTeXRIS
BibTeX
@article{josiah2026synergistic,
  title = {{Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia}},
  author = {Angeline Josiah and Ryan Low and Alisha Ganesh and Gretchen Vamvakidis and Adeline Kintono and Ibrahim Tohidi‐Esfahani and Maya Latimer and Judith Trotman},
  journal = {EJHaem},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13691637},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Synergistic Activity of Venetoclax and Rituximab in Multiply Relapsed or Refractory Waldenström Macroglobulinaemia
AU  - Angeline Josiah
AU  - Ryan Low
AU  - Alisha Ganesh
AU  - Gretchen Vamvakidis
AU  - Adeline Kintono
AU  - Ibrahim Tohidi‐Esfahani
AU  - Maya Latimer
AU  - Judith Trotman
PY  - 2026
DA  - 2026/10/01
JO  - EJHaem
UR  - https://europepmc.org/article/PMC/PMC13691637
SN  - 2688-6146
ER  -